Home/Filings/4/0001562180-23-000948
4//SEC Filing

Nolte Alexander 4

Accession 0001562180-23-000948

CIK 0001395937other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:58 PM ET

Size

5.4 KB

Accession

0001562180-23-000948

Insider Transaction Report

Form 4
Period: 2023-02-02
Nolte Alexander
Chief Accounting Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2023-02-02$28.55/sh+17,000$485,35017,000 total
    Exercise: $28.55Exp: 2033-02-02Common Stock (17,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option shall vest monthly over a four-year period.

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1
  • filerCIK 0001891979

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:58 PM ET
Size
5.4 KB